Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lyrica® (pregabalin) – Expanded indication
May 23, 2019 - The FDA approved Pfizer’s Lyrica (pregabalin) capsules and oral solution as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.
